ORPHAZYME Investor Inform: Investors With Sizeable Losses Have Possibility to Lead the Orpahzyme A/S Course Action Lawsuit
SAN DIEGO, July 12, 2021--(Small business WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers of Orphazyme A/S (NASDAQ: ORPH)...
